Michael Ernst Fassbender
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Michael Ernst Fassbender has a total of 243 co-authors. Here are the top co-authors by number of shared publications:
- Jonathan W. Engle
University of Wisconsin−Madison
19 shared publications - Kevin D. John
Los Alamos National Laboratory, Los Alamos, NM 87545, USA
18 shared publications - Francois M. Nortier
Los Alamos National Laboratory, P.O. Box 1663, Los Alamos, NM 87545, United States
16 shared publications Eva R. Birnbaum
Chemistry Division, Los Alamos National Laboratory, P.O. Box 1663, Los Alamos, NM, 87545, USA
14 shared publications- Beau Ballard
ORNL
11 shared publications Mark Brugh
Los Alamos National Laboratory, Los Alamos, NM, USA
11 shared publications
Latest Publications
- Open Access
Purification of Actinium-225 from Thorium via Selective Precipitation
Numerous promising cancer treatments currently in clinical trials rely on the production and purification of actinium-225 (225Ac), an actinide with alpha emissions that can kill cancer cells via targeted alpha therapy. To enable ongoing and future studies, and to support anticipated future demand, it is necessary to increase the supply of 225Ac. High-energy proton irradiation of thorium metal (Th0(s)) is one of the leading production methods of 225Ac. This process requires the chemical separation of microscopic amounts (μg) of 225Ac from large quantities (>10 g) of thorium. Current methods to accomplish this thorium removal step can be slow, tedious, generate large quantities of radioactive liquid waste, and require very strict control of the processing conditions. To improve this separation, we investigated the ability of four nitrate salts (NH4NO3, KNO3, RbNO3, and CsNO3) to act as selective Th4+ (aq) precipitation agents in the presence of 225Ac3+(aq) in aqueous nitric acid to allow for their separation through a simple filtration. First, we used an automated separations platform to screen the ability of these nitrate salts to precipitate Th4+. We found the Th4+ precipitation yields and amount of precipitating agent needed to maximize this yield were dependent on the identity of the precipitating agent cation. Separation studies with 225Ac3+(aq) and subsequent down-selection of the most promising Th4+ precipitating agents and conditions enabled us to develop its effective selective precipitation. We demonstrated that the separation was compatible with Th0(s) quantities that can produce medically relevant amounts of 225Ac. We observed 99.9% of Th4+(aq) could be removed via precipitation with KNO3(s) in less than two hours in the presence of co-produced isotopes. Meanwhile, other experiments demonstrated that the 225Ac3+(aq) recovery was > 97% at 1–10 g Th0(s) scale.
Open AccessPurification of Actinium-225 from Thorium via Selective Precipitation
Numerous promising cancer treatments currently in clinical trials rely on the production and purification of actinium-225 (225Ac), an actinide with alpha emissions that can kill cancer cells via targeted alpha therapy. To enable ongoing and future studies, and to support anticipated future demand, it is necessary to increase the supply of 225Ac. High-energy proton irradiation of thorium metal (Th0(s)) is one of the leading production methods of 225Ac. This process requires the chemical separation of microscopic amounts (μg) of 225Ac from large quantities (>10 g) of thorium. Current methods to accomplish this thorium removal step can be slow, tedious, generate large quantities of radioactive liquid waste, and require very strict control of the processing conditions. To improve this separation, we investigated the ability of four nitrate salts (NH4NO3, KNO3, RbNO3, and CsNO3) to act as selective Th4+ (aq) precipitation agents in the presence of 225Ac3+(aq) in aqueous nitric acid to allow for their separation through a simple filtration. First, we used an automated separations platform to screen the ability of these nitrate salts to precipitate Th4+. We found the Th4+ precipitation yields and amount of precipitating agent needed to maximize this yield were dependent on the identity of the precipitating agent cation. Separation studies with 225Ac3+(aq) and subsequent down-selection of the most promising Th4+ precipitating agents and conditions enabled us to develop its effective selective precipitation. We demonstrated that the separation was compatible with Th0(s) quantities that can produce medically relevant amounts of 225Ac. We observed 99.9% of Th4+(aq) could be removed via precipitation with KNO3(s) in less than two hours in the presence of co-produced isotopes. Meanwhile, other experiments demonstrated that the 225Ac3+(aq) recovery was > 97% at 1–10 g Th0(s) scale.
- 19 July 2022
- Published by Office of Scientific and Technical Information (OSTI)
Introduction to nuclear reactions and the new Device for Indirect Capture Experiments on Radionuclides [Slides]
The U.S. Department of Energy's Office of Scientific and Technical Information
- 19 July 2022
- Published by Office of Scientific and Technical Information (OSTI)
Introduction to nuclear reactions and the new Device for Indirect Capture Experiments on Radionuclides [Slides]
The U.S. Department of Energy's Office of Scientific and Technical Information
- 31 August 2021
- Published by Office of Scientific and Technical Information (OSTI)
225Ac/213Bi Generator Based on Millifluidics Controlled Electrodeposition
The U.S. Department of Energy's Office of Scientific and Technical Information
- 31 August 2021
- Published by Office of Scientific and Technical Information (OSTI)
225Ac/213Bi Generator Based on Millifluidics Controlled Electrodeposition
The U.S. Department of Energy's Office of Scientific and Technical Information
- 14 December 2020
- Published by Springer Nature in Nature Chemistry
- Vol. 13 (3) , 284-289
Developing the 134Ce and 134La pair as companion positron emission tomography diagnostic isotopes for 225Ac and 227Th radiotherapeutics
Developing targeted α-therapies has the potential to transform how diseases are treated. In these interventions, targeting vectors are labelled with α-emitting radioisotopes that deliver destructive radiation discretely to diseased cells while simultaneously sparing the surrounding healthy tissue. Widespread implementation requires advances in non-invasive imaging technologies that rapidly assay therapeutics. Towards this end, positron emission tomography (PET) imaging has emerged as one of the most informative diagnostic techniques. Unfortunately, many promising α-emitting isotopes such as 225Ac and 227Th are incompatible with PET imaging. Here we overcame this obstacle by developing large-scale (Ci-scale) production and purification methods for 134Ce. Subsequent radiolabelling and in vivo PET imaging experiments in a small animal model demonstrated that 134Ce (and its 134La daughter) could be used as a PET imaging candidate for 225AcIII (with reduced 134CeIII) or 227ThIV (with oxidized 134CeIV). Evaluating these data alongside X-ray absorption spectroscopy results demonstrated how success relied on rigorously controlling the CeIII/CeIV redox couple.
- 14 December 2020
- Published by Springer Nature in Nature Chemistry
- Vol. 13 (3) , 284-289
Developing the 134Ce and 134La pair as companion positron emission tomography diagnostic isotopes for 225Ac and 227Th radiotherapeutics
Developing targeted α-therapies has the potential to transform how diseases are treated. In these interventions, targeting vectors are labelled with α-emitting radioisotopes that deliver destructive radiation discretely to diseased cells while simultaneously sparing the surrounding healthy tissue. Widespread implementation requires advances in non-invasive imaging technologies that rapidly assay therapeutics. Towards this end, positron emission tomography (PET) imaging has emerged as one of the most informative diagnostic techniques. Unfortunately, many promising α-emitting isotopes such as 225Ac and 227Th are incompatible with PET imaging. Here we overcame this obstacle by developing large-scale (Ci-scale) production and purification methods for 134Ce. Subsequent radiolabelling and in vivo PET imaging experiments in a small animal model demonstrated that 134Ce (and its 134La daughter) could be used as a PET imaging candidate for 225AcIII (with reduced 134CeIII) or 227ThIV (with oxidized 134CeIV). Evaluating these data alongside X-ray absorption spectroscopy results demonstrated how success relied on rigorously controlling the CeIII/CeIV redox couple.
- 1 November 2020
- Published by Elsevier in Nuclear Medicine and Biology
- Vol. 90-91, 69-73
A reverse 230U/226Th radionuclide generator for targeted alpha therapy applications
- 1 November 2020
- Published by Elsevier in Nuclear Medicine and Biology
- Vol. 90-91, 69-73
A reverse 230U/226Th radionuclide generator for targeted alpha therapy applications
- 1 February 2020
- Published by Elsevier in Applied Radiation and Isotopes
- Vol. 156, 108973
Production of 230Pa by proton irradiation of 232Th at the LANL isotope production facility: Precursor of 230U for targeted alpha therapy
- 1 February 2020
- Published by Elsevier in Applied Radiation and Isotopes
- Vol. 156, 108973
Production of 230Pa by proton irradiation of 232Th at the LANL isotope production facility: Precursor of 230U for targeted alpha therapy
- Open Access
- 10 January 2020
- Published by Springer Nature in Scientific Reports
- Vol. 10 (1) , 1-3
Guest Edited Collection: Radioisotopes and radiochemistry in health science
Radioisotopes can be produced artificially from stable nuclei through the interaction with particles or highly energetic photons. In combination with modern detection and counting techniques, radioisotopes and radiochemical methods uniquely contribute to the health sciences. This Collection showcases salient aspects of medical radioisotope science ranging from the production, recovery and purification of radioisotopes to the methods used to attach them to biomolecules. The Collection also presents studies that highlight the importance of radiochemistry in the assessment of environmental radioactivity.
- 10 January 2020
- Published by Springer Nature in Scientific Reports
- Vol. 10 (1) , 1-3
Open AccessGuest Edited Collection: Radioisotopes and radiochemistry in health science
Radioisotopes can be produced artificially from stable nuclei through the interaction with particles or highly energetic photons. In combination with modern detection and counting techniques, radioisotopes and radiochemical methods uniquely contribute to the health sciences. This Collection showcases salient aspects of medical radioisotope science ranging from the production, recovery and purification of radioisotopes to the methods used to attach them to biomolecules. The Collection also presents studies that highlight the importance of radiochemistry in the assessment of environmental radioactivity.
- 14 May 2018
- Published by American Chemical Society (ACS) in Analytical Chemistry
- Vol. 90 (11) , 7012-7017
Separation of Protactinium Employing Sulfur-Based Extraction Chromatographic Resins
Protactinium-230 (t1/2 17.4 d) is the parent isotope of 230U (t1/2 20.8 d), a radionuclide of interest for targeted alpha therapy (TAT). Column chromatographic methods have been developed to separate no-carrier-added 230Pa from proton irradiated thorium targets and accompanying fission products. Results reported within demonstrate the use of novel sulfur bearing chromatographic extraction resins for the selective separation of protactinium. The recovery yield of 230Pa was 93 ± 4 % employing a R3P=S type commercially available resin and 88 ± 4 % employing a DGTA (diglycothioamide) containing custom synthesized extraction chromatographic resin. The radiochemical purity of the recovered 230Pa was measured via high purity germanium -ray spectroscopy to be > 99.5 % with the remaining radioactive contaminant being 95Nb due to its similar chemistry to protactinium. Measured equilibrium distribution coefficients for protactinium, thorium, uranium, niobium, radium, and actinium on both the R3P=S type and the DGTA resin in hydrochloric acid media are reported - to the best of our knowledge, for the first time.
- 14 May 2018
- Published by American Chemical Society (ACS) in Analytical Chemistry
- Vol. 90 (11) , 7012-7017
Separation of Protactinium Employing Sulfur-Based Extraction Chromatographic Resins
Protactinium-230 (t1/2 17.4 d) is the parent isotope of 230U (t1/2 20.8 d), a radionuclide of interest for targeted alpha therapy (TAT). Column chromatographic methods have been developed to separate no-carrier-added 230Pa from proton irradiated thorium targets and accompanying fission products. Results reported within demonstrate the use of novel sulfur bearing chromatographic extraction resins for the selective separation of protactinium. The recovery yield of 230Pa was 93 ± 4 % employing a R3P=S type commercially available resin and 88 ± 4 % employing a DGTA (diglycothioamide) containing custom synthesized extraction chromatographic resin. The radiochemical purity of the recovered 230Pa was measured via high purity germanium -ray spectroscopy to be > 99.5 % with the remaining radioactive contaminant being 95Nb due to its similar chemistry to protactinium. Measured equilibrium distribution coefficients for protactinium, thorium, uranium, niobium, radium, and actinium on both the R3P=S type and the DGTA resin in hydrochloric acid media are reported - to the best of our knowledge, for the first time.
- 2 March 2018
- Published by Royal Society of Chemistry (RSC) in Dalton Transactions
- Vol. 47 (15) , 5189-5195
Synthesis and radiometric evaluation of diglycolamide functionalized mesoporous silica for the chromatographic separation of actinides Th, Pa and U
Grafting of DGA on mesoporous silica affords a sorbent with the potential to separate U from Pa and Th.
- 2 March 2018
- Published by Royal Society of Chemistry (RSC) in Dalton Transactions
- Vol. 47 (15) , 5189-5195
Synthesis and radiometric evaluation of diglycolamide functionalized mesoporous silica for the chromatographic separation of actinides Th, Pa and U
Grafting of DGA on mesoporous silica affords a sorbent with the potential to separate U from Pa and Th.